To view the fulltext, please log in
To view the pdf, please log in
Squamous cell carcinoma of the prostate is uncommon. In an attempt to assess the incidence of squamous cell carcinoma of the prostate, we searched the records of the Saskatchewan Cancer Agency over the past 30 years. Using strict diagnostic criteria a total of 6 cases of pure squamous cell carcinoma among 13,497 cases of prostatic carcinoma were identified. The ages of these patients ranged from 42 to 85 years. The survival rates of these cases ranged from 1 to 13 months.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- Mott LDM: Squamous cell carcinoma of the prostate: Report of 2 cases and review of the literature. J Urol 1979;121:833–835.
- Nabi G, Ansari MS, Singh I, Sharma MC, Dogra PN: Primary squamous cell carcinoma of the prostate: A rare clinicopathological entity. Report of 2 cases and review of literature. Urol Int 2001;66:216–219.
- Imamura M, Nishiyama H, Ohmori K, Nishimura K: Squamous cell carcinoma of the prostate without evidence of recurrence 5 years after operation. Urol Int 2000;65:122–124.
- Corder MP, Cicmil GA: Effective treatment of metastatic squamous cell carcinoma of the prostate with adriamycin. J Urol 1976;115:222.
- Little NA, Wiener JS, Walther PJ, Paulson DF, Anderson EE: Squamous cell carcinoma of the prostate: 2 cases of a rare malignancy and review of the literature. J Urol 1993;149:137–139.
- Okada E, Kamizaki H: Primary squamous cell carcinoma of the prostate. Int J Urol 2000;7:347–350.
- Majeed F, Javed TA, Khan AU, Koerber RK: Primary squamous cell carcinoma of the prostate: A novel chemotherapy regimen. J Urol 2002;168:640.
- Gray GF Jr, Marshall VF: Squamous carcinoma of the prostate. J Urol 1975;113:736–738.
- Shukla GS, Singhal RL: Hormone-independent polyamine metabolism of squamous cell carcinoma of the prostate. Cell Biochem Funct 1985;3:185–192.